Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

2310016E02Rik Inhibitors

CChemical inhibitors of 2310016E02Rik can exert their inhibitory action through diverse molecular pathways, each targeting a specific aspect of the protein's function. Staurosporine, a potent kinase inhibitor, can impede the function of 2310016E02Rik by broadly inhibiting the phosphorylation processes essential for its activity. This universal blockade of kinase activity can lead to a wide-ranging suppression of 2310016E02Rik's functional role in cellular signaling. Similarly, Bisindolylmaleimide I can inhibit 2310016E02Rik by specifically targeting Protein Kinase C (PKC), thereby disrupting the PKC-mediated signaling pathways that 2310016E02Rik may rely on. LY294002, by inhibiting PI3K, can obstruct the PI3K/AKT pathway, which is often crucial for the activation and function of proteins like 2310016E02Rik. Rapamycin, by inhibiting mTOR, can disrupt signaling pathways associated with mTOR that are necessary for 2310016E02Rik's activity.

Further, inhibitors like PD98059 and U0126 can impede the function of 2310016E02Rik by selectively blocking MEK1/2, which is integral to the MEK/ERK pathway, a signaling cascade that 2310016E02Rik may be regulated by. SB203580 targets the p38 MAPK signaling pathways, which can inhibit 2310016E02Rik if its function is associated with p38 MAPK activity. SP600125 acts upon JNK, and its inhibitory effect can prevent JNK-mediated signaling that is essential for the activity of 2310016E02Rik. PP2, by selectively inhibiting Src family tyrosine kinases, can disrupt signaling pathways that rely on these kinases for the regulation of 2310016E02Rik. Dasatinib, which inhibits Src family kinases and c-KIT, can block the pathways controlled by these kinases that may be crucial for the function of 2310016E02Rik. Erlotinib, by targeting EGFR tyrosine kinase, can interfere with EGFR signaling pathways that are necessary for 2310016E02Rik's function. Lastly, Sorafenib's inhibition of multiple kinases, including RAF, can impede RAF signaling pathways that are essential for the functional activity of 2310016E02Rik.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$85.00
$132.00
$287.00
$495.00
$3752.00
42
(0)

Erlotinib inhibits EGFR tyrosine kinase, which can lead to the functional inhibition of 2310016E02Rik by interfering with EGFR signaling pathways that may be necessary for 2310016E02Rik's activity.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Sorafenib targets multiple kinases including RAF, which can inhibit 2310016E02Rik by impeding RAF signaling pathways that could be essential for the functional activity of 2310016E02Rik.